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We report a case with spurious hyperchloremia with negative anion gap in a child who was taking potassium bromide for refractory
epilepsy. Blood chemistry showed a high chloride level (171mEq/L) and a negative anion gap (−52mEq/L). Plasma chloride
concentration is measured by an ion-selective electrode method; however the presence of other anions like bromide and iodides
can interfere with chloride level and largely overestimates the chloride concentration. Thus hyperchloremia with a negative anion
gap is a clue to the diagnosis of halides like bromide and iodide ingestion.
1. Introduction
Falsely elevated serum chloride level with negative anion gap
is an uncommon occurrence and most likely due to labora-
tory error. A similar finding on consecutive electrolytes esti-
mation suggests ingestion of medications containing halides
such as bromide or iodide.
2. Case Presentation
A twelve-year-old girl, with past medical history of Dravet
syndrome and developmental delay, presented to our hos-
pital emergency department with altered sensorium, one-
day history of fever up to 105.6 F, decreased oral intake
and urine output, fatigue, and intermittent cough. Seizure
frequency was unchanged. Her home medications were
valproic acid, clobazam, potassium bromide, and diazepam.
On arrival to the emergency room she was found to be
hypotensive (65/39mmHg), tachycardic, and febrile. She
received two normal saline boluses. Her laboratory results in
emergency room included serum sodium 143mEq/L, potas-
sium 4.3mEq/L, chloride 171mEq/L, bicarbonate 24mEq/L,
Blood Urea Nitrogen (BUN) 12mg/dL, serum creatinine
0.57mg/dL, calcium 9.2mg/dL, blood glucose of 60mg/dL,
and valproic acid level 23.7mcg/L (therapeutic level 50–
100mcg/L), and normal liver function tests were performed.
Her capillary blood gas revealed pH 7.40, PCO
2
37.1mmHg,
bicarbonate 23.2mEq/L, and base deficit −1mEq/L. In the
pediatric intensive care unit (PICU) patient remained stable,
received intravenous fluids, was tested positive for influenza,
and started on oseltamivir. Repeat electrolyte panel onmulti-
ple occasions, as shown in Table 1, had hyperchloremia (154–
171mEq/L) with negative anion gap (−40 to −52mEq/L).
Due to persistent hyperchloremia and as the patient takes
potassium bromide for the past two years for refractory
seizures possibility of bromide toxicity was considered. On
day one of admission to PICU, potassium bromide therapy
was stopped and serum bromide level was sent. The bro-
mide level was 691mcg/mL (normal therapeutic range 200–
1000mcg/mL). Despite normal bromide level in our patient
potassium bromide was temporarily withheld and continued
on IV hydration therapy. Over the next three days serum
chloride and child’s clinical condition improved.
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Table 1: This table shows serial electrolytes, anion gap, and calcu-
lated serum osmolality.
Serum parameter Day of admission
Day 1 Day 2 Day 3 Day 4
Sodium mEq/L 143 143 136 138
Potassium mEq/L 4.2 4.7 4.4 4.4
Chloride mEq/L 171 162 154 154
Bicarbonate mEq/L 24 26 22 25
Glucose mg/dL 97 93 180 96
BUN mg/dL 12 3 3 4
Creatinine mg/dL 0.5 0.4 0.3 0.4
Calcium mg/dL 9.2 9.2 8.3 9
Anion gap mEq/L −52 −43 −40 −41
Calculated osmolality mOsm/Kg 295 292 283 281
Bromide level mcg/mL 691
3. Discussion
Dravet syndrome is a rare genetic encephalopathy with
intractable epilepsy, also known as severe myoclonic or poly-
morphic epilepsy in infancy. Seizures in Dravet syndrome
are resistant to treatment and requiremultiple anticonvulsant
medications including bromide to control seizures [1]. Potas-
siumbromide has sedative and anticonvulsant properties. It is
been used as anticonvulsantmedication especially in children
with refractory seizures. The drug has very high bioavailabil-
ity, and its half-life is 9–12 days [2]. It has a narrow therapeutic
index and intoxication is known to occur evenwith therapeu-
tic doses [2]. Other bromide-containing compounds, dex-
tromethorphan bromide and pyridostigmine bromide, are
also known to cause spurious hyperchloremia and negative
anion gap [3, 4].
Bromide toxicity presents with confusion, lethargy,
ataxia, tremor, cerebral edema, and other neuropsychiatric
symptoms like acute psychosis anddelirium [5].Gastric intol-
erance, anorexia, weight loss, and skin lesions like acne form-
ing dermatitis are also described as adverse effects [6]. Our
index patient did not show any neuropsychiatric symptoms
or skin lesions. It is postulated that at high levels bromide
ion replaces the chloride in nerve transport mechanisms,
stabilizes neuronal membrane, and impairs the nerve trans-
mission [6].
Bromide is a negatively charged anion similar to chloride.
Plasma chloride concentration can be measured by coulome-
try and colorimetric and ion-selective electrodemethods.The
presence of other anions like bromide and iodides can inter-
fere with chloride level and largely overestimates the chloride
concentration. The degree of chloride overestimation is low-
est with coulometry method and highest with ion electrode
method [7]. Each bromide ion reacts with more than three
chloride ions. A serum bromide level of 5mEq/L measures
an additional 20mEq/L of chloride ions [8]. This spurious
hyperchloremia can also be seen with severe hyperlipidemia
and salicylate poisoning [9, 10]. Specific assay with induc-
tively coupled plasma mass spectrometry confirms the pres-
ence of bromide level. Apart from bromide ingestion, iodide,
lithium intoxication, and monoclonal proteinemia can give
rise to negative anion gap [11]. Treatment with aggressive
rehydration and diuretic s improves the bromide toxicity and
in refractory cases hemodialysis may be needed [7].
4. Conclusion
In our index patient, the systemic symptoms can be
attributable to influenza infection. However, uncertain cor-
relation between bromide level and toxic symptoms [7] and
improvement of patient’s sensorium and serum chloride level
with ongoing hydration makes bromide toxicity a possible
diagnosis. Bromide toxicity should be suspected in any child
on bromide containing drug therapy presenting with neuro-
logical symptoms along with hyperchloremia and a negative
anion gap.
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